A unique case of Bloom syndrome with a combination of genetic hits: A lesson from trio-based exome sequencing: A case report

Varování

Publikace nespadá pod Fakultu sportovních studií, ale pod Přírodovědeckou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

WAYHELOVÁ Markéta VALLOVÁ Vladimíra BROŽ Petr MIKULÁŠOVÁ Aneta MACHÁČKOVÁ Dominika FILKOVÁ Hana Dynková SMETANA Jan TAKÁCSOVÁ Alena GAILLYOVÁ Renata KUGLÍK Petr

Rok publikování 2023
Druh Článek v odborném periodiku
Časopis / Zdroj Molecular Medicine Reports
Fakulta / Pracoviště MU

Přírodovědecká fakulta

Citace
www https://doi.org/10.3892/mmr.2023.12997
Doi http://dx.doi.org/10.3892/mmr.2023.12997
Klíčová slova exome sequencing; BLM gene; Bloom syndrome; cancer-predisposing syndrome; copy-number neutral loss of heterozygosity
Popis Pathogenic variants affecting the BLM gene are responsible for the manifestation of extremely rare cancer-predisposing Bloom syndrome. The present study reports on a case of an infant with a congenital hypotrophy, short stature and abnormal facial appearance. Initially she was examined using a routine molecular diagnostic algorithm, including the cytogenetic analysis of her karyotype, microarray analysis and methylation-specific MLPA, however, she remained undiagnosed on a molecular level. Therefore, she and her parents were enrolled in the project of trio-based exome sequencing (ES) using Human Core Exome kit. She was revealed as a carrier of an extremely rare combination of causative sequence variants altering the BLM gene (NM_000057.4), c.1642C>T and c.2207_2212delinsTAGATTC in the compound heterozygosity, resulting in a diagnosis of Bloom syndrome. Simultaneously, a mosaic loss of heterozygosity of chromosome 11p was detected and then confirmed as a borderline imprinting center 1 hypermethylation on chromosome 11p15. The diagnosis of Bloom syndrome and mosaic copy-number neutral loss of heterozygosity of chromosome 11p increases a lifetime risk to develop any types of malignancy. This case demonstrates the trio-based ES as a complex approach for the molecular diagnostics of rare pediatric diseases.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info